selected scholarly activity
-
chapters
- Osteoarthritis. 259-277. 2015
-
conferences
- Clinical Presentation and Treatment of Oligoarticular Psoriatic Arthritis in Canada: High Frequency of Smaller Joint Involvement. Arthritis & Rheumatology. 2019
- Human Resources Committee's Subgroup-interpretation of Student Recruitment Activities. Journal of Rheumatology. 932-932. 2017
- Predictors of Canadian Adult Rheumatologist Clinical Workload and Working Hours. Journal of Rheumatology. 883-884. 2017
- Anatomical Patterns Suggest the Involvement of Biomechanical Stress in the Pathogenesis of Erosions in Rheumatoid Arthritis. Arthritis & Rheumatology. 2016
- What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?. Arthritis & Rheumatology. 2016
- #MakeRheum for Rheumatology: Testing Novel Ways to Increase Interest in Rheumatology by Canadian Undergraduate and Postgraduate Medical Trainees. Journal of Rheumatology. 1165-1165. 2016
- A Longitudinal Pilot Study Investigating Changes in Metacarpophalangeal Erosive Damage and Functional Ability in Patients with Rheumatoid Arthritis Using Magnetic Resonance Imaging and Computerized Segmentation. Journal of Rheumatology. 1200-1201. 2016
- FRI0187 A Randomized Crossover Comparison of Injection Site Pain with 40 Mg/0.8 Ml and 40 mg/0.4 ml Formulations of Adalimumab in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 497.3-498. 2016
- Measuring the Rheumatologist Workforce in Canada: Stand Up and Be Counted!. Journal of Rheumatology. 1204-1205. 2016
- Understanding Erosions Inside-Out: Erosion Depth Predicts Bone Repair over 2 Years in Rheumatoid Arthritis. Journal of Rheumatology. 1152-1153. 2016
- Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis?. Arthritis & Rheumatology. 2015
- Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand up and be Counted Survey. Arthritis & Rheumatology. 2015
- Early Erosions in Rheumatoid Arthritis (EERA) Software Reliably Measures Erosive Damage on MRI in the Metacarpophalangeal Joints of Rheumatoid Arthritis Patients. Journal of Rheumatology. 1320-1321. 2015
- The Efficacy and Safety of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA at Week 97 (SUMMACTA). Journal of Rheumatology. 1285-1285. 2015
- Training the Rheumatologists of Tomorrow: The Learners Experience. Journal of Rheumatology. 1284-1285. 2015
- Training the Rheumatologists of Tomorrow: The WOMAC Experience. Journal of Rheumatology. 1310-1311. 2015
- Assessing the Validity and Reliability of a Novel MRI Semi-Automated Algorithm for Quantifying Bone Loss in the Hand.. Arthritis & Rheumatology. S515-S515. 2014
- Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-Ray Erosion Detection.. Arthritis & Rheumatology. S628-S629. 2014
- The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis. Arthritis & Rheumatology. S692-S692. 2014
- Training the Rheumatologists of Tomorrow: The Canadian Experience.. Arthritis & Rheumatology. S1260-S1260. 2014
- Rheumatologists of Tomorrow: One School's Story. Journal of Rheumatology. 1512-1513. 2014
- SAT0576 Creating New Rheumatologists: the Canadian Experience. Annals of the Rheumatic Diseases. 798.3-799. 2014
- Patient preferences and willingness to pay for enhancements to subcutaneous injection devices used to treat psoriasis. Journal of American Academy of Dermatology. AB178-AB178. 2014
- Are Needs Being Addressed? Mapping the Evolution of Canadian Rheumatologists' Gaps and Challenges in the Last Decade. Journal of Rheumatology. 957-957. 2013
- Longterm Safety of Rituximab in Rheumatoid Arthritis Clinical Trials: A 10-Year Followup Study. Journal of Rheumatology. 957-957. 2013
- Optimal Care of Rheumatoid Arthritis and Spondyloarthropathies: A Road Going Through Enhanced Collaboration and Communication for Canadian Rheumatologists. Journal of Rheumatology. 975-975. 2013
- Reliability of the Early Erosions in Rheumatoid Arthritis Software when Quantifying Bone Loss. Journal of Rheumatology. 1020-1020. 2013
- Relative, Reliability-Adjusted Diagnostic Test Accuracy of Erosion Detection Between Magnetic Resonance Imaging and Radiography in Rheumatoid Arthritis. Arthritis and Rheumatism. S888-S888. 2012
- Reliability of the Early Erosions in Rheumatoid Arthritis Software When Quantifying Bone Loss.. Arthritis and Rheumatism. S441-S441. 2012
- The Effect of Evaluation Variability At the Unit of Measurement On the Reliability of Omeract Ramris and Van Der Heijde-Modified Sharp Score.. Arthritis and Rheumatism. S440-S440. 2012
- A Case Report of Hemophagocytic Syndrome in a Patient with Dermatomyositis. Journal of Rheumatology. 1745-1745. 2012
- On-line Case Simulation Versus Paper Format: The Ability to Screen for Arthritis Using GALS. Journal of Rheumatology. 1746-1746. 2012
- On-line vs Paper Format Learning: Identifying Inflammatory Arthritis Early: Randomized Control Trial. Journal of Rheumatology. 1746-1747. 2012
- The Gait, Arms, Legs & Spine (GALS) Exam: An Effective Screening Tool for Rheumatoid Arthritis When Used by Family Physicians and Nurse Practitioners. Journal of Rheumatology. 1719-1719. 2012
- The Gait, Arms, Legs & Spine Exam: An Effective Screening Tool for Rheumatoid Arthritis When Used by Family Physicians and Nurse Practitioners.. Arthritis and Rheumatism. S30-S30. 2011
- Assessing the Rate of Serious Infections in Rheumatoid Arthritis (RA) Patients who Receive Other Biologic Therapies after Discontinuing Rituximab (RTX). Journal of Rheumatology. 1165-1165. 2011
- Demyelinating events in Seniors with Rheumatoid Arthritis (RA): A Population-based Study. Journal of Rheumatology. 1158-1159. 2011
- Disease Activity in Patients Prescribed Biologics in Ontario: Results from the OBRI. Journal of Rheumatology. 1160-1160. 2011
- Safety Analysis of Tocilizumab (TCZ) in Rheumatoid Arthritis (RA) Patients (pts): Long-Term Extension Studies (Median of 3.1 Years of Treatment). Journal of Rheumatology. 1164-1164. 2011
- The Incidence of Herpes Zoster in Seniors with Rheumatoid Arthritis: A Population-Based Study. Journal of Rheumatology. 1159-1159. 2011
- Baseline Characteristics and Preliminary Efficacy Results of Patients Receiving Biologic and Traditional Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Ontario: Results from the OBRI. Journal of Rheumatology. 1280-1280. 2010
- Patient Self Reported Health Related Quality of Life Improves with Effective Treatment in Early Inflammatory Arthritis (EIA). Journal of Rheumatology. 1329-1329. 2010
- Rheumatoid Arthritis(RA) and Risk of Serious Infections: A Nested Case-Control Study from the Ontario Biologics Research Initiative. Journal of Rheumatology. 1279-1279. 2010
- Serious Fungal Infections in Seniors with Rheumatoid Arthritis(RA): A Population-based Study from the Ontario Biologics Research Initiative. Journal of Rheumatology. 1279-1279. 2010
- The Sensitivity and Specificity of the GALS (Gait, Arms, Legs, Spine) Examination when used by Physiotherapists to Detect Rheumatoid Arthritis. Journal of Rheumatology. 1338-1338. 2010
- Under Utilization of DMARDs in Early Rheumatoid Arthritis: A Population-Based Study from the Ontario Biologics Research Initiative Comparing Rheumatology Care with Primary Care. Journal of Rheumatology. 1348-1348. 2010
- An Evaluation of the Potential Effects of a National Consensus Statement on Optimal Treatment of Early Rheumatoid Arthritis in Ontario. Journal of Rheumatology. 2589-2590. 2009
- Baseline Characteristics of Patients Receiving Biologic and DMARD Therapy in Ontario: Results from the Ontario Biologics Research Initiative. Journal of Rheumatology. 2565-2566. 2009
- Continued Inhibition of Structural Damage in Rheumatoid Arthritis Patients Treated with Rituximab at 2 Years: REFLEX Study. Journal of Rheumatology. 2592-2593. 2009
- Medication Exposures and Serious Infections in a Population-based Cohort of Older Individuals with Rheumatoid Arthritis (RA). Journal of Rheumatology. 2590-2590. 2009
- Patients with Rheumatoid Arthritis Achieve a Rapid Response When Treated with Certolizumab Pegol Irrespective of Background Treatment. Journal of Rheumatology. 2568-2568. 2009
- Serious Infections in a Population-based Cohort of Older Individuals with Rheumatoid Arthritis. Journal of Rheumatology. 2565-2565. 2009
- Successful Clinical Outcomes in Canadian Early Inflammatory Arthritis Patients: Data from the CATCH Study. Journal of Rheumatology. 2591-2591. 2009
- Use of Biologic Response Modifying Drugs by Ontario Rheumatology Specialists: 2008 Update. Journal of Rheumatology. 2590-2590. 2009
- Impact of a video on learning the GALS musculoskeletal screening exam in medical students. Arthritis and Rheumatism. S198-S198. 2008
- Serious infections in a population-based cohort of older individuals with rheumatoid arthritis. Arthritis and Rheumatism. S270-S270. 2008
- The GALS screening tool: A quick and easy screen for MSK conditions in the primary care setting. Arthritis and Rheumatism. S749-S750. 2008
- A qualitative study to determine best methods for post-marketing surveillance in usual rheumatology care in Ontario. Journal of Rheumatology. 1199-1199. 2008
- GALS exam identifies musculoskeletal abnormalities not previously identified in routine family practice. Journal of Rheumatology. 1210-1211. 2008
- Impact of a training video on learning the GALS screening examination in medical students. Journal of Rheumatology. 1175-1176. 2008
- Impact of a video on learning the GALS musculoskeletal screening exam in medical students. Journal of Rheumatology. 1203-1203. 2008
- Improved clinical and simplified disease activity index (CDAI, SDAI) scores with rituximab in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors. Journal of Rheumatology. 1191-1191. 2008
- Validation of the GALS musculoskeletal screening exam for use in primary care: A pilot study. BMC Musculoskeletal Disorders. 1212-1212. 2008
- Efficacy and safety of adalimumab (Humira (R)) in Canadian clinical practice: Results from the canact trial. Journal of Rheumatology. 1609-1609. 2007
- Efficacy of adalimumab (Humira (R)) in Canadian clinical practice: Subanalysis of the canact trial for patients with moderate vs. severe rheumatoid arthritis. Journal of Rheumatology. 1605-1605. 2007
- Prolonged efficacy of rituximab in rheumatoid arthritis patients and inadequate response to one or more TNF inhibitors: 1-year follow-up of a subset of patients receiving a single course in a controlled trial (reflex study). Journal of Rheumatology. 1604-1605. 2007
- Rituximab improves health-related quality of life as measured by the SF-36: Domain score results from the reflex study. Journal of Rheumatology. 1604-1604. 2007
- Use of biologic response modifying drugs by Ontario rheumatology specialists.. Journal of Rheumatology. 1607-1607. 2007
- Efficacy and safety of adalimumab (Humira (R)) in Canadian clinical practice: Results from the canact trial. Annals of the Rheumatic Diseases. 320-320. 2006
- Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The CanACT and the ReACT trial. Journal of Rheumatology. 1401-1401. 2005
- Efficacy and safety of adalimumab (HUMIRA (R)) in Canadian clinical practice. A comparison of the Canadian and the European practice: The canact and the react trial to. Annals of the Rheumatic Diseases. 425-425. 2005
- An assessment of safety of daily subcutaneous (SC) injections of kineret (TM) (anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice population of patients with rheumatoid arthritis (RA). Journal of Rheumatology. 1877-1877. 2003
- Assessment of changes in patient function, measured by the health assessment questionnaire - Disability index (HAQ-DI), following daily subcutaneous (SC) injections of kineret (TM) (anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice population of patents with rheumatoid arthritis (RA). Journal of Rheumatology. 1878-1878. 2003
- Demonstrated safety with daily subcutaneous (SC) injections of Kineret (R) (Anakinra "C recombinant interleukin-1 receptor antagonist) in a standard practice population. Annals of the Rheumatic Diseases. 194-195. 2003
- Patient function improved as measured by the health assessment questionnaire - Disability index (HAQ-DI), following daily subcutaneous (SC) injections of kineret; (Anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice populatio. Annals of the Rheumatic Diseases. 422-422. 2003
- A randomized multi-site controlled trial of group psychotherapy(GPT) for SLE.. Arthritis and Rheumatism. S149-S149. 2000
- QUALITY OF LIFE IN SLE DURING ACTIVE AND INACTIVE DISEASE STATES. Psychosomatic Medicine. 102-102. 1999
- Results of a prospective long-term study of the effects of early institution of 2nd-line agents in rheumatoid arthritis.. Arthritis and Rheumatism. 140-140. 1997
- Fluoride therapy in the prevention of rheumatoid arthritis induced bone loss.. Journal of Bone and Mineral Research. S641-S641. 1997
- Intermittent cyclical etidronate therapy for the prevention of rheumatoid arthritis induced bone loss following 18 months of fluoride therapy or placebo.. Journal of Bone and Mineral Research. S642-S642. 1997
- A randomized, double-blind, placebo-controlled trial of the effects of fluoride on lumbar spine bone mineral density in patients with rheumatoid arthritis.. Arthritis and Rheumatism. 661-661. 1996
- Osteoarthritis of the knee: Viscosupplementation with hylan G-F20 in clinical practice.. Arthritis and Rheumatism. 1192-1192. 1996
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONES LOSS - 2 YEARS OF FOLLOW-UP. Arthritis and Rheumatism. 1441-1441. 1995
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP. Journal of Bone and Mineral Research. S253-S253. 1995
- INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 2 YEARS OF FOLLOW-UP. Arthritis and Rheumatism. R34-R34. 1995
- INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS. Arthritis and Rheumatism. S51-S51. 1993
- VITAMIN-D AND CALCIUM IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS - FOLLOW-UP OVER 3 YEARS. Arthritis and Rheumatism. S51-S51. 1993
- INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS. Journal of Bone and Mineral Research. S325-S325. 1993
- NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS. Arthritis and Rheumatism. S120-S120. 1992
- NASAL SALMON-CALCITONIN IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS. Journal of Bone and Mineral Research. S193-S193. 1992
-
journal articles
- Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. Clinical and Experimental Rheumatology. 41:2249-2256. 2023
- Impact of interactive multi-media learning for physicians in musculoskeletal education – a pilot study. BMC Medical Education. 22:718. 2022
- Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. Journal of Rheumatology. 49:447-453. 2022
- Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort. PLoS ONE. 17:e0274264-e0274264. 2022
- Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. Journal of Rheumatology. 49:16-25. 2022
- Canadian Rheumatologists’ Perspectives on Moderate Psoriatic Arthritis and Oligoarticular Psoriatic Arthritis. Journal of Rheumatology. 48:1692-1697. 2021
- Factors influencing rheumatology residents’ decision on future practice location. Canadian Medical Education Journal. 12:e63-e68. 2021
- Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative—a rheumatoid arthritis cohort. Journal of Clinical Epidemiology. 114:95-103. 2019
- Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. Journal of Rheumatology. 46:874-886. 2019
-
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase
III Study. Arthritis & Rheumatology. 71:878-891. 2019 - Planning for the Rheumatologist Workforce. Journal of Clinical Rheumatology. 25:142-146. 2019
- Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss. Arthritis Care and Research. 71:300-307. 2019
- ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). RMD Open. 4:e000738-e000738. 2018
- Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada. Journal of Rheumatology. 44:248-257. 2017
- Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis. Rheumatology and Therapy. 3:257-270. 2016
- Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. Rheumatology. 55:1751-1762. 2016
- How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the “Training the Rheumatologists of Tomorrow” Project. Journal of Rheumatology. 43:788-798. 2016
- High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study. Journal of Rheumatology. 43:657-665. 2016
- Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort. Journal of Rheumatology. 42:2023-2028. 2015
- Assessing the Reliability of a Semiautomated Segmentation Algorithm for Quantifying Erosions in the Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis. Journal of Rheumatology. 42:1582-1586. 2015
- A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial. Trials. 15:268. 2014
- Earlier Time to Remission Predicts Sustained Clinical Remission in Early Rheumatoid Arthritis — Results from the Canadian Early Arthritis Cohort (CATCH). Journal of Rheumatology. 41:2161-2166. 2014
- Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. Rheumatology. 53:1075-1086. 2014
- NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis and Cartilage. 22:17-25. 2014
- Serious infections in a population‐based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care and Research. 65:353-361. 2013
- Effect of Rheumatologist Education on Systematic Measurements and Treatment Decisions in Rheumatoid Arthritis: The Metrix Study. Journal of Rheumatology. 39:2247-2252. 2012
- Screening for signs and symptoms of rheumatoid arthritis by family physicians and nurse practitioners using the Gait, Arms, Legs, and Spine musculoskeletal examination. Arthritis Care and Research. 64:1923-1927. 2012
- Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study. BMC Musculoskeletal Disorders. 12:261. 2011
- The sensitivity, specificity and reliability of the GALS (gait, arms, legs and spine) examination when used by physiotherapists and physiotherapy students to detect rheumatoid arthritis. Physiotherapy. 97:196-202. 2011
- Quality care in seniors with new‐onset rheumatoid arthritis: A Canadian perspective. Arthritis Care and Research. 63:53-57. 2011
- The Challenges of Developing Online Learning. Journal of Rheumatology. 36:470-471. 2009
- Potential effects of a national consensus statement on optimal treatment of early rheumatoid arthritis in Ontario. Scandinavian Journal of Rheumatology, Supplement. 38:390-391. 2009
- Validation of the GALS musculoskeletal screening exam for use in primary care: a pilot study. BMC Musculoskeletal Disorders. 9:115. 2008
- Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage. 12:642-649. 2004
- Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology. 43:992-999. 2004
- Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus.. Journal of Rheumatology. 30:1011-1016. 2003
- Counterbalancing patient demands with evidence: Results from a pan-canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus. Annals of Behavioral Medicine. 24:88-99. 2002
- Living with lupus: a prospective pan-Canadian study.. Journal of Rheumatology. 28:2442-2448. 2001
- Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.. Journal of Rheumatology. 27:623-629. 2000
- Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physical health. Arthritis and Rheumatism. 12:401-410. 1999
- 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.. Journal of Rheumatology. 26:1545-1549. 1999
- A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus. Lupus. 7:80-85. 1998
- A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.. Lupus. 7:80-85. 1998
- Corticosteroid-induced osteoporosis.. Journal of the American Medical Women's Association. 53:25-40. 1998
- Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.. Journal of Rheumatology. 24:2308-2313. 1997
- Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis. Rheumatology. 36:255-259. 1997
- A Model for Osteoporosis Education of Students and Health Professionals. Therapeutic Innovation and Regulatory Science. 31:287-291. 1997
- Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.. Journal of Rheumatology. 23:1579-1585. 1996
- Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.. Journal of Rheumatology. 23:995-1000. 1996
- SALSALATE, A NONACETYLATED SALICYLATE, IS AS EFFICACIOUS AS DICLOFENAC IN PATIENTS WITH RHEUMATOID-ARTHRITIS. Journal of Rheumatology. 22:617-624. 1995
- A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA study. American Journal of Medicine. 98:156-168. 1995
- Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.. Journal of Rheumatology. 21:1922-1926. 1994
- Primary angiitis of the CNS diagnosed by angiography. QJM - Monthly Journal of the Association of Physicians. 87:351-358. 1994
- Interrater reliability of the tender point criterion for fibromyalgia.. Journal of Rheumatology. 21:370-371. 1994
- Interrater reliability of the tender point criterion for fibromyalgia.. Journal of Rheumatology. 19:1955-1959. 1992
- Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study [see comments]. Blood. 80:975-980. 1992
- Hydroxychloroquine in Systemic Lupus Erythematosus. New England Journal of Medicine. 325:1046-1046. 1991
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus. New England Journal of Medicine. 324:150-154. 1991
- The Relationship of Antiphospholipid Antibodies to Thromboembolic Disease in Systemic Lupus Erythematosus: A Cross-Sectional Study. Thrombosis and Haemostasis. 66:520-524. 1991
- Gold induced thrombocytopenia: 12 cases and a review of the literature. Seminars in Arthritis and Rheumatism. 16:287-293. 1987